CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained ...

The "U.S. Insulin Pen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been ...

Rising Diabetes Rates and Digital InnovatioFuel European Insulin Pen Market Growth European Insulin Pen Market European ...

CVS Health agreed to pay $37.76 million to settle allegations that it dispensed too many insulin pens to patients and ...

For a decade, CVS knew it was skirting rules meant to limit overprescribing but did nothing to stop, according to the ...

Adults with type 1 diabetes using a continuous glucose monitoring system with a smart insulin pen attained a higher time in range if they responded more frequently to alerts for missed doses or high ...

Switzerland: Adults with type 1 diabetes using CGM and a smart insulin pen achieved higher time in range when they ...

Despite its small base, rapid growth in smart insulin administration, connected devices, patient-centric care, and home-based ...

United States Attorney for the Southern District of New York, Jay Clayton, Special Agent in Charge of the New York Regional Office of the U.S. Department of Health and Human Services Office of the ...

CVS Health Corp. has agreed to pay $37.76 million to resolve a False Claims Act lawsuit alleging that its pharmacies ...

Getting to grips with rising diabetes rates is arguably one of the most urgent tasks for South Africa's public healthcare system, but the setbacks keep coming. While some communities are facing ...

A national pharmacy chain agreed to a $37.76 million settlement after federal investigators found it dispensed excess insulin ...